Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-22-039256
Filing Date
2022-12-22
Accepted
2022-12-22 21:33:18
Documents
1
Period of Report
2022-12-13

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3765
  Complete submission text file 0000899243-22-039256.txt   5405
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Issuer) CIK: 0001042418 (see all company filings)

EIN.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address BIODELIVERY SCIENCES INTERNATIONAL, INC 4131 PARKLAKE AVENUE, SUITE #225 RALEIGH NC 27612
Business Address
ODONNELL FRANCIS E JR (Reporting) CIK: 0001066040 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-13467 | Film No.: 221483237